Profile of:
Mirjam De Vries
2002 Medical doctor degree at Leiden University, 2007 Master degree in clinical epidemiology at EMGO Institute/VU University medical center, 2013 PhD degree at VU University medical center in the field of axial spondyloarthritis, 2015 Rheumatologist specialisation at VU University medical center. Currently working at Karolinska University Hospital and Institute. Certified in musculoskeletal ultrasound. MSUS intermediate course 2024.
Full name: Mirjam De Vries
Current country: Sweden
Membership level: Full
Type of membership: Member
Number of publications: 12
Tuberculosis Risk in Ankylosing Spondylitis, Other Spondyloarthritis, and Psoriatic Arthritis in Sweden: A Population-Based Cohort Study (2018)
https://pubmed.ncbi.nlm.nih.gov/29195024/
C-reactive protein polymorphisms influence serum CRP-levels independent of disease activity in ankylosing spondylitis (2015)
https://pubmed.ncbi.nlm.nih.gov/25603416/
The relationship between disease-related characteristics and conduction disturbances in ankylosing spondylitis (2010)
https://pubmed.ncbi.nlm.nih.gov/20132069/
Discovertebral (Andersson) lesions in severe ankylosing spondylitis: a study using MRI and conventional radiography (2010)
https://pubmed.ncbi.nlm.nih.gov/20496041/
pANCA, ASCA, and OmpC antibodies in patients with ankylosing spondylitis without inflammatory bowel disease (2010)
https://pubmed.ncbi.nlm.nih.gov/20810508/
Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation (2009)
https://pubmed.ncbi.nlm.nih.gov/19822712/
Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis (2009)
https://pubmed.ncbi.nlm.nih.gov/18375542/
Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis (2009)
https://pubmed.ncbi.nlm.nih.gov/19877087/
Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis (2009)
https://pubmed.ncbi.nlm.nih.gov/19404933/
Discovertebral (Andersson) lesions of the spine in ankylosing spondylitis revisited (2009)
https://pubmed.ncbi.nlm.nih.gov/19294478/
Inefficacy of infliximab in ankylosing spondylitis is correlated with antibody formation (2007)
https://pubmed.ncbi.nlm.nih.gov/17178760/
Decreased clinical response to infliximab in ankylosing spondylitis is correlated with anti-infliximab formation (2007)
https://pubmed.ncbi.nlm.nih.gov/17472991/
